Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$36.14 - $42.24 $381,674 - $446,096
-10,561 Reduced 96.0%
440 $15,000
Q2 2021

Jul 19, 2021

BUY
$39.85 - $46.63 $121,462 - $142,128
3,048 Added 38.33%
11,001 $450,000
Q1 2021

Apr 26, 2021

BUY
$42.34 - $52.82 $320,302 - $399,583
7,565 Added 1949.74%
7,953 $346,000
Q3 2020

Oct 27, 2020

BUY
$38.56 - $48.36 $14,961 - $18,763
388 New
388 $16,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.